Cosmeceuticals and natural health productsCosmeceuticals and natural health products

News

Case Medical, Inc.® Instrument Trays Demonstrate Enhanced Performance when used in TSO3's Superior Low-Temperature STERIZONE® Sterilization System

News - Case Medical, Inc.® a vertically integrated, product development and manufacturer offering custom designed and modular "do-it-yourself" sterilization systems for the medical industry, and TSO3 Inc (TSX: TSO3), a leading innovator and developer of low-temperature sterilization systems for the healthcare industry, jointly announced today that SteriTite instrument containers and MediTray inserts engineered and manufactured by Case Medical demonstrate excellent compatibility with TSO3's new STERIZONE® VP4 Sterilizer, which is now cleared for sale in the USA.

3rd round of financing of Feldan for $1.2M

News - Members of Anges Québec, the Anges Québec Capital Fund and Fier Succès reiterated their confidence in Feldan, a Quebec company that develops cell therapy products, with a new investment of over $1.2M. With this third round of financing completed, the biotechnology company can now rely on a $675K investment from 15 angels, including Jean-Marc Rousseau and Sylvain Chartier, $475K from the Anges Québec Capital Fund and $75K from Fier Succès.

CO2 Solutions Receives $400,000 Assistance Contribution from Canada Economic Development for Quebec Regions (CED)

News - CO2 Solutions Inc. (TSX-V: CST), a leader in low-cost carbon dioxide (CO2) capture, is pleased to announce that it has received a $400,000 commitment from Canada Economic Development for Quebec Regions (CED) towards optimization of the Corporation's carbon capture process and new enzyme production at industrial scale.

TSO3 enters into first commercial agreement for STERIZONE® VP4 Sterilizer

News - TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced that the Company has signed its first commercial agreement with Getinge Infection Control in support of the launch of the STERIZONE® VP4 Sterilization System. The non-exclusive agreement covers multiple markets in which Getinge has significant market share, including North America and other selected markets. Efforts to launch the product will begin immediately.

B-TEMIA appoints Mr. Steven Smith as Vice President of Business Development

News - B-TEMIA Inc., a leader in the growing market of human augmentation, announces the appointment of Mr Steven Smith as Vice President Business Development. Mr Smith has extensive industry experience in the home medical equipment market and, in particular, in the commercialization of mobility devices that will be very valuable for the commercialization of KeeogoTM.

H2O Innovation's fast response to drought stricken California community

News - H2O Innovation Inc., leader in membrane filtration, is proud to have successfully delivered a containerized advanced water treatment system to the Cambria Community Service District, California ("Cambria") to help this community overcome the impact of a 10 year drought affecting the Golden State. The system, designed to be used during the dry months, produces a flow rate of 587 gpm (3,200 m3/d).

H2O Innovation announces $14 million in new contracts and implementation of a proprietary remote monitoring solution SPMCTM for a municipality in Florida

News - H2O Innovation Inc. announced that it was awarded, at the end of its second quarter and in January 2015, six (6) new contracts for an aggregate amount of $14 million, mainly for the supply of drinking water systems to municipal customers. With the addition of these new contracts, the backlog for water treatment projects has reached $38.2 M at the beginning of the third quarter. In addition, H2O Innovation is pleased to announce the implementation of its proprietary remote monitoring solution, SPMCTM (System Performance Monitoring Center), at a municipality located in Florida for a period of three (3) years.

Medicago awarded a contract by the U.S. Department of Health and Human Services to explore alternate production methods for Ebola antibodies

News - Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services (HHS) for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp™, from Mapp Biopharmaceutical.

The Québec City Convention Centre will host an international congress on chronic societal cardiometabolic diseases

News - From July 8 to 12, 2015, between 700 and 800 specialists of abdominal obesity, type 2 diabetes, cardiovascular diseases, nutrition and physical activity will take part in this international scientific event. Close to forty speakers are already confirmed.

Instrument Trays Made of Solvay's Radel® PPSU Show Strong Compatibility with TSO3's Low-Temperature Sterilization System

News - Solvay, a leading global supplier of high-performance thermoplastics, and TSO3 Inc., a leading developer of low-temperature sterilization systems for the healthcare industry, jointly announced that, as part of the U.S. FDA’s 510(k) premarket clearance for TSO3’s new STERIZONE® VP4 Sterilization System received in December 2014, light weight instrument trays made of Solvay Specialty Polymer’s Radel® polyphenylsulfone (PPSU) resin demonstrate strong compatibility for sterilizing a wide range of medical devices.

Contacts

Jean-MichelGarroLife Sciences

More details

Newsletter

Subscribe to our newsletter for interesting news and information.

Print this page